Overall rank by patents
#43,921
of 49,997 tracked assignees
USPTO PatentsView assignee record - 6 granted patents across 7 technology areas, recorded in grant years 2015–2018. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Ventirx ranks #43,921 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 7 technology areas.
USPTO PatentsView assignee plate
Corpus R43921 · US Corporation #43,921 · 6 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL
Nearest grant-volume peer: Velocity Systems LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
J-Devices · near
25 score
Toontrack Music AB · near
25 score
Bond Manufacturing · near
25 score
The Decor Pty · near
25 score
VentiRx Pharmaceutic… · this assignee
25 score
3D Lighting… · lowest
7 score
What this shows Ventirx's Innovation Score is 24.6/100 (15th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
VentiRx Pharmaceuticals, Inc. is a focused PatentsView assignee: 7 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (2 grants) versus a trough of 1 in 2016. By volume, Ventirx sits between Velocity Systems LLC and VerifyMe, Inc..
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Velocity Systems LLC
6 patents
Vengo Inc.
6 patents
Venn Biosciences Corporation
6 patents
Venn Technology Corporation
6 patents
VentriFlo, Inc.
6 patents
Veolia Environment VE
6 patents
Verdant Lighting Technology, Inc.
6 patents
VerifyMe, Inc.
6 patents
VentiRx Pharmaceuticals, Inc.
6 patents
What this shows VentiRx holds 6 patents at rank #43,939, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #43,939 in granted patent volume.
Other assignees with the most granted patents in VentiRx's primary technology class.
Two PlainPatent-derived peer sets for VentiRx, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (25 here).
Ventirx's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
25 15th percentile higher than 15% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 33.3% |
| 2016 | 1 | 16.7% |
| 2017 | 2 | 33.3% |
| 2018 | 1 | 16.7% |
Top 7 of 7 technology areas
Overall rank by patents
#43,921
of 49,997 tracked assignees
24.6 out of 100
What to do with this data
VentiRx Pharmaceuticals, Inc.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.